Changeflow GovPing Healthcare & Life Sciences KAO Corporation External Skin Preparation Paten...
Routine Rule Added Final

KAO Corporation External Skin Preparation Patent US12605315B2

Favicon for changeflow.com USPTO Patent Grants - Pharma (A61K)
Published
Detected
Email

Summary

USPTO granted Patent US12605315B2 to KAO Corporation on April 21, 2026, for an external skin preparation containing tabular metal oxide (A) with thickness 30-360 nm and aspect ratio 50-300, combined with UV absorbent (B) in a mass ratio of 0.1 to 5. The patent also covers formulations combining metal oxide (A), UV scattering agent (C), and nonvolatile oil (D), plus a method for protecting skin from IR and UV rays. Inventors are Takashi Fukui and Noriko Tejima, with 11 claims allowed under CPC classifications A61K 8/29, A61K 8/27, A61K 8/92, and related categories.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Grants - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.

What changed

USPTO issued Patent US12605315B2 to KAO Corporation on April 21, 2026, covering external skin preparations that combine tabular metal oxide (A) with UV-absorbing and scattering agents. The primary embodiment claims a ratio of metal oxide to UV absorbent (A/B) by mass of 0.1 to 5; secondary claims cover formulations with UV scattering agent and nonvolatile oil at (A/C) ratios of 0.1 to 18. The patent also protects a method for protecting skin from IR and UV rays.

Pharmaceutical and cosmetics manufacturers developing UV-protective topical formulations should review this patent for freedom-to-operate considerations. The specific combination of tabular metal oxide with defined thickness (30-360 nm) and aspect ratio (50-300) with UV actives represents potentially protected subject matter. Competitors in the sunscreen and dermatological skincare space should evaluate their formulations against these claims.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

External skin preparation

Grant US12605315B2 Kind: B2 Apr 21, 2026

Assignee

KAO CORPORATION

Inventors

Takashi Fukui, Noriko Tejima

Abstract

The present invention relates to [1] an external skin preparation containing a tabular metal oxide (A) having a thickness of 30 to 360 nm and an aspect ratio of 50 to 300, and a UV absorbent (B) in a ratio [(A)/(B)] by mass of 0.1 to 5; [2] an external skin reparation containing the tabular metal oxide (A), a UV scattering agent (C) and a nonvolatile oil (D) in a ratio [(A)/(C)] by mass of 0.1 to 18; and [3] a method for protecting skin from IR rays and UV rays by applying the external skin preparation to skin.

CPC Classifications

A61K 8/29 A61K 8/27 A61K 8/92 A61K 2800/413 A61K 2800/522 A61Q 17/04

Filing Date

2019-12-27

Application No.

17417573

Claims

11

View original document →

Get daily alerts for USPTO Patent Grants - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 21st, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent grant IP licensing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!